Erowid.org: Erowid Reference 6276 : Human hallucinogenic drug research in the United States: a present-day case history and review of the process : Strassman RJ

Erowid References Database

Strassman RJ. “Human hallucinogenic drug research in the United States: a present-day case history and review of the process”. J Psychoactive Drugs. 1991 Jan-Mar;23(1):29-38. <a name="ref">Strassman RJ.</a> <a href="/references/6276">"Human hallucinogenic drug research in the United States: a present-day case history and review of the process"</a> <i>J Psychoactive Drugs</i>. 1991 Jan-Mar;23(1):29-38.
Show Articles by Strassman RJ Article IDs Erowid RefID: 6276 PubMedID: 1941365 Collections Hofmann Collection MDMA Collection All References	Abstract Legitimate human research with hallucinogenic drugs, although of great theoretical and practical interest, involves daunting regulatory hurdles that have discouraged investigators from attempting such work. Using the example of the author's own application for and receipt of federal permission to administer N,N-dimethyltryptamine (DMT) to humans, this article reviews the application process, obstacles and their solutions, and the local and federal issues involved. Further human research with hallucinogens is possible if a persistent and collaborative effort is made with the relevant institutions that oversee the performance of this type of research.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]